<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Create AET02-style AE summary table — AET02_table • dtlg</title><!-- favicons --><link rel="icon" type="image/png" sizes="96x96" href="../favicon-96x96.png"><link rel="icon" type="”image/svg+xml”" href="../favicon.svg"><link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png"><link rel="icon" sizes="any" href="../favicon.ico"><link rel="manifest" href="../site.webmanifest"><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/Nunito-0.4.10/font.css" rel="stylesheet"><link href="../deps/Inconsolata-0.4.10/font.css" rel="stylesheet"><link href="../deps/Source_Sans_Pro-0.4.10/font.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Create AET02-style AE summary table — AET02_table"><meta name="description" content="Summarises adverse events in a format similar to the AET02 table from a CSR,
showing total AE counts, patients with AEs, and a breakdown by System Organ
Class (SOC) and Preferred Term (PT)."><meta property="og:description" content="Summarises adverse events in a format similar to the AET02 table from a CSR,
showing total AE counts, patients with AEs, and a breakdown by System Organ
Class (SOC) and Preferred Term (PT)."></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-none" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">dtlg</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.3</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/benchmarks.html">Benchmarks</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-topic">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Create AET02-style AE summary table</h1>

      <div class="d-none name"><code>AET02_table.Rd</code></div>
    </div>

    <div class="ref-description section level2">
    <p>Summarises adverse events in a format similar to the AET02 table from a CSR,
showing total AE counts, patients with AEs, and a breakdown by System Organ
Class (SOC) and Preferred Term (PT).</p>
    </div>

    <div class="section level2">
    <h2 id="ref-usage">Usage<a class="anchor" aria-label="anchor" href="#ref-usage"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span><span class="fu">AET02_table</span><span class="op">(</span></span>
<span>  <span class="va">adsl</span>,</span>
<span>  <span class="va">adae</span>,</span>
<span>  <span class="va">patient</span>,</span>
<span>  <span class="va">treat</span>,</span>
<span>  target <span class="op">=</span> <span class="st">"AEDECOD"</span>,</span>
<span>  rows_by <span class="op">=</span> <span class="st">"AEBODSYS"</span>,</span>
<span>  indent <span class="op">=</span> <span class="fu"><a href="nbsp.html">nbsp</a></span><span class="op">(</span>n <span class="op">=</span> <span class="fl">4L</span><span class="op">)</span></span>
<span><span class="op">)</span></span></code></pre></div>
    </div>

    <div class="section level2">
    <h2 id="arguments">Arguments<a class="anchor" aria-label="anchor" href="#arguments"></a></h2>


<dl><dt id="arg-adsl">adsl<a class="anchor" aria-label="anchor" href="#arg-adsl"></a></dt>
<dd><p>Subject-level dataset.</p></dd>


<dt id="arg-adae">adae<a class="anchor" aria-label="anchor" href="#arg-adae"></a></dt>
<dd><p>Adverse event dataset.</p></dd>


<dt id="arg-patient">patient<a class="anchor" aria-label="anchor" href="#arg-patient"></a></dt>
<dd><p>Unique subject identifier variable.</p></dd>


<dt id="arg-treat">treat<a class="anchor" aria-label="anchor" href="#arg-treat"></a></dt>
<dd><p>Treatment arm variable.</p></dd>


<dt id="arg-target">target<a class="anchor" aria-label="anchor" href="#arg-target"></a></dt>
<dd><p>Preferred term variable for grouping (default: <code>"AEDECOD"</code>).</p></dd>


<dt id="arg-rows-by">rows_by<a class="anchor" aria-label="anchor" href="#arg-rows-by"></a></dt>
<dd><p>Higher-level term for nesting (default: <code>"AEBODSYS"</code>).</p></dd>


<dt id="arg-indent">indent<a class="anchor" aria-label="anchor" href="#arg-indent"></a></dt>
<dd><p>Character or string to indent nested rows (default: 4 non-breaking spaces).</p></dd>

</dl></div>
    <div class="section level2">
    <h2 id="value">Value<a class="anchor" aria-label="anchor" href="#value"></a></h2>
    <p>A merged data.table containing AE summary.</p>
    </div>

    <div class="section level2">
    <h2 id="ref-examples">Examples<a class="anchor" aria-label="anchor" href="#ref-examples"></a></h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span><span class="co"># Create a AET02 table</span></span></span>
<span class="r-in"><span><span class="fu">AET02_table</span><span class="op">(</span></span></span>
<span class="r-in"><span>  adsl <span class="op">=</span> <span class="va">adsl</span>,</span></span>
<span class="r-in"><span>  adae <span class="op">=</span> <span class="va">aesi</span>,</span></span>
<span class="r-in"><span>  patient <span class="op">=</span> <span class="st">"USUBJID"</span>,</span></span>
<span class="r-in"><span>  treat <span class="op">=</span> <span class="st">"ARM"</span>,</span></span>
<span class="r-in"><span>  target <span class="op">=</span> <span class="st">"AEDECOD"</span>,</span></span>
<span class="r-in"><span>  rows_by <span class="op">=</span> <span class="st">"AEBODSYS"</span>,</span></span>
<span class="r-in"><span>  indent <span class="op">=</span> <span class="st">"  "</span></span></span>
<span class="r-in"><span><span class="op">)</span></span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                                stats   A: Drug X B: Placebo</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                               &lt;char&gt;      &lt;char&gt;     &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:    Total number of patients with at least one AE 100 (74.6%) 98 (73.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:                              Total number of AEs         502        480</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:                                           cl B.2                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:                                    dcd B.2.1.2.1  52 (38.8%) 51 (38.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:                                    dcd B.2.2.3.1  50 (37.3%) 55 (41.0%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:                           Total number of events         102        106</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7: Total number of patients with at least one event  62 (46.3%) 56 (41.8%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:                                           cl D.1                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:                                    dcd D.1.1.1.1  52 (38.8%) 40 (29.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:                                    dcd D.1.1.4.2  54 (40.3%) 44 (32.8%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:                           Total number of events         106         84</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12: Total number of patients with at least one event  64 (47.8%) 54 (40.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:                                           cl A.1                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:                                    dcd A.1.1.1.1  57 (42.5%) 43 (32.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:                                    dcd A.1.1.1.2  58 (43.3%) 56 (41.8%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:                           Total number of events         115         99</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17: Total number of patients with at least one event  68 (50.7%) 58 (43.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:                                           cl D.2                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:                                    dcd D.2.1.5.3  49 (36.6%) 57 (42.5%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20:                           Total number of events          49         57</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21: Total number of patients with at least one event  37 (27.6%) 46 (34.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:                                           cl B.1                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23:                                    dcd B.1.1.1.1  44 (32.8%) 43 (32.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24:                           Total number of events          44         43</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25: Total number of patients with at least one event  38 (28.4%) 37 (27.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26:                                           cl C.2                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27:                                    dcd C.2.1.2.1  39 (29.1%) 40 (29.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28:                           Total number of events          39         40</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29: Total number of patients with at least one event  28 (20.9%) 36 (26.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30:                                           cl C.1                       </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31:                                    dcd C.1.1.1.3  47 (35.1%) 51 (38.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32:                           Total number of events          47         51</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33: Total number of patients with at least one event  36 (26.9%) 34 (25.4%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                                stats   A: Drug X B: Placebo</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                               &lt;char&gt;      &lt;char&gt;     &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     C: Combination</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>             &lt;char&gt;</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  1:    103 (78.0%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  2:            604</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  3:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  4:     59 (44.7%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  5:     68 (51.5%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  6:            127</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  7:     74 (56.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  8:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>  9:     64 (48.5%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 10:     50 (37.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 11:            114</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 12:     68 (51.5%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 13:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 14:     74 (56.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 15:     63 (47.7%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 16:            137</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 17:     76 (57.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 18:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 19:     65 (49.2%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 20:             65</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 21:     50 (37.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 22:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 23:     50 (37.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 24:             50</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 25:     36 (27.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 26:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 27:     57 (43.2%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 28:             57</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 29:     48 (36.4%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 30:               </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 31:     54 (40.9%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 32:             54</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 33:     36 (27.3%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>     C: Combination</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>             &lt;char&gt;</span>
<span class="r-in"><span></span></span>
</code></pre></div>
    </div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Max Ebenezer-Brown, Max Norman, Xinye Li, Anja Peebles-Brown, Ramiro Magno.</p>
</div>

<div class="pkgdown-footer-right">

</div>

    </footer></div>





  </body></html>

